Viewing Study NCT00221650

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2026-01-24 @ 6:34 AM
Study NCT ID: NCT00221650
Status: COMPLETED
Last Update Posted: 2007-06-13
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
Sponsor: University Hospital, Bordeaux
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Hepatitis C, Chronic View
None Treatment Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis C, Chronic View
None HCV infection View
None HIV infection View
None Treatment Failure View
None PEG interferon View
None Interferons/therapeutic use View
None Interferon Alfa-2a/adverse effects View
None Ribavirin/therapeutic use View
None Ribavirin/adverse effects View
None Drug Therapy, Combination View
None Treatment Experienced View
None Treatment Naive View